CA
NURO

CoreCap Advisors’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

CoreCap Advisors’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-117
Closed -$464 – 3347
2024
Q4 		$464 Hold
117
– – ﹤0.01% 2542
2024
Q3 		$464 Buy
+117
New +$429 ﹤0.01% 2376
2024
Q2 		– Sell
-117
Closed -$497 – 2663
2024
Q1 		$497 Buy
+117
New +$407 ﹤0.01% 2332

Other funds holding NURO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CoreCap Advisors's NURO Position: Q1 2025 in Review

CoreCap Advisors sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2025, closing a stake of 117 shares — an estimated $464 sold.

CoreCap Advisors first reported a position in NURO in Q1 2024 and held it in 3 quarters. The position peaked at $497 in Q1 2024. 14 funds tracked by Wall St. Rank hold NURO as of Q1 2025.

  • CoreCap Advisors reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • CoreCap Advisors sold 117 NeuroMetrix, Inc. Common Stock shares in Q1 2025, an estimated $464.
  • CoreCap Advisors first reported a position in NeuroMetrix, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • CoreCap Advisors's NeuroMetrix, Inc. Common Stock position peaked at $497 in Q1 2024.
  • 14 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2025.

Based on CoreCap Advisors's 13F filing for Q1 2025, filed 9 May 2025.